Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
547.87
-2.75 (-0.50%)
Nov 22, 2024, 4:00 PM EST - Market closed
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.04B in the quarter ending September 30, 2024, with 16.88% growth. This brings the company's revenue in the last twelve months to $7.87B, up 14.83% year-over-year. In the year 2023, Intuitive Surgical had annual revenue of $7.12B with 14.49% growth.
Revenue (ttm)
$7.87B
Revenue Growth
+14.83%
P/S Ratio
24.66
Revenue / Employee
$575,234
Employees
13,676
Market Cap
195.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
| Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
| Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
| Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
| Dec 31, 2019 | 4.48B | 754.30M | 20.25% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck & Co. | 63.17B |
| Pfizer | 59.38B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher | 42.37B |
| Abbott Laboratories | 41.22B |
| Amgen | 32.53B |
| Danaher | 23.74B |
ISRG News
- 4 days ago - Intuitive Surgical Is Breaking Ground - Seeking Alpha
- 4 weeks ago - ISRG Stock To $5,000 - Forbes
- 5 weeks ago - Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake - Benzinga
- 5 weeks ago - Intuitive Surgical Stock Hits Record High on da Vinci Device Demand - Investopedia
- 5 weeks ago - Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued - Seeking Alpha
- 5 weeks ago - Intuitive Surgical, Inc. (ISRG) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Intuitive beats quarterly profit estimates on strong demand for surgical robots - Reuters
- 5 weeks ago - Intuitive Surgical's stock rises after third-quarter results beat on jump in robotic surgeries - Market Watch